Neuphoria Therapeutics Inc (NEUP) Stock Price, Quote, News & History

NEUPNASDAQ
$3.77
-0.12-3.11%
Last update: Aug 5, 8:45 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-17.15M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
18.62M
Free Cash Flow (TTM)
-17.15M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
1.47M

Analyst Trends and Forecast

1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.89M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.72
Earnings Yield % (TTM)
-200.51%
Earnings Yield % (FWD)
-62.28%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.44

Company Debt

Total Debt
$34.23K
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$19.44M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.89
Close
-
Volume / Avg.
27.17K / 195.07K
Day Range
$3.84 - $3.96
52 Wk Range
3.19 - 21.40
Market Cap
$20.37M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
0.28%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Neuphoria Therapeutics (NEUP) stock?

A

You can purchase shares of Neuphoria Therapeutics (NASDAQ:NEUP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Neuphoria Therapeutics (NEUP) competitors?

A

There are no as such competitors for Neuphoria Therapeutics.

Q

What is the forecast, or price target, for Neuphoria Therapeutics (NEUP) stock?

A

Neuphoria Therapeutics has a consensus price target of $35.00.

Q

What is the current price for Neuphoria Therapeutics (NEUP)?

A

The stock price for Neuphoria Therapeutics (NASDAQ: NEUP) is $3.7692 last updated August 5, 2026 at 8:45 AM EDT.

Q

Does Neuphoria Therapeutics (NEUP) pay a dividend?

A

There are no upcoming dividends for Neuphoria Therapeutics.

Q

When is Neuphoria Therapeutics (NASDAQ:NEUP) reporting earnings?

A

Neuphoria Therapeutics does not have any upcoming earnings scheduled.

Q

Is Neuphoria Therapeutics (NEUP) going to split?

A

There is no upcoming split for Neuphoria Therapeutics.

Q

What sector and industry does Neuphoria Therapeutics (NEUP) operate in?

A

Neuphoria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.